| GCEGX | GCEJX | GCEGX / GCEJX | |
| Total Expense Ratio | 2.01 | 1.01 | 199% |
| Annual Report Gross Expense Ratio | 3.22 | 2.22 | 145% |
| Fund Existence | 6 years | 6 years | - |
| Gain YTD | 20.612 | 21.180 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 41.9M | 41.9M | 100% |
| Annual Yield % from dividends | 0.76 | 1.31 | 58% |
| Returns for 1 year | 43.47 | 44.78 | 97% |
| Returns for 3 years | 21.97 | 23.46 | 94% |
| Returns for 5 years | 6.32 | 11.82 | 53% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MEMHX | 51.45 | 0.73 | +1.44% |
| MFS Emerging Markets Equity R4 | |||
| BPSIX | 29.75 | 0.36 | +1.22% |
| Boston Partners Small Cap Value II I | |||
| MXCCX | 8.28 | 0.08 | +0.98% |
| Federated Hermes Max-Cap Index C | |||
| LYFCX | 16.34 | 0.04 | +0.25% |
| AlphaCentric Life Sciences & Hlthcare C | |||
| OSMCX | 28.90 | 0.07 | +0.24% |
| Invesco International Small-Mid Com C | |||